New cancer clinical trial: Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Published on: March 29, 2018 at 12:00PM
Conditions:   Hepatocellular Carcinoma;   Biliary Tract Cancer
Interventions:   Drug: Tremelimumab;   Drug: Durvalumab;   Radiation: Radiation
Sponsors:   Massachusetts General Hospital;   AstraZeneca
Not yet recruiting
https://ift.tt/2J7y8pq